ArticleCPT: pharmacometrics & systems pharmacologyPublished
Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung Cancer
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- CPT: pharmacometrics & systems pharmacology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Body Weight; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Dose-Response Relationship, Drug; Mutation; Adult; Aged; Middle Aged
- PubMed ID
- 42166539
- PubMed Central ID
- PMC13239558
- Open access
- Yes, open
- Added to directory
- Source checked